Company Abingdon Health Plc OTC Markets

Equities

ABDXF

GB00BLF79J41

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 09:32:19 2022-08-19 am EDT 5-day change 1st Jan Change
0.07 USD -.--% Intraday chart for Abingdon Health Plc -.--% -.--%

Business Summary

Abingdon Health plc provides lateral flow contract development and manufacturing (CDMO services) and related contract services to an international customer base. It offers its services to an international customer base across industry sectors, which include clinical, self-testing, animal health, plant health, and environmental testing. Its segments include Product sales, Contract manufacturing, Contract development, and Regulatory. Its regulatory services include technical file build, regulatory filing support, implementation of quality management systems and quality assurance. The Company’s CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing.

Sales per Business

GBP in Million2022Weight2023Weight Delta
Contract Development
56.9 %
1 44.0 % 2 56.9 % +84.67%
Contract Manufacturing
26.2 %
1 39.6 % 1 26.2 % -5.78%
Pocket Diagnostic Products and Other Tests
10.3 %
0 16.4 % 0 10.3 % -10.11%
Regulatory
6.6 %
- - 0 6.6 % -

Sales per region

GBP in Million2022Weight2023Weight Delta
United Kingdom
32.3 %
1 50.0 % 1 32.3 % -7.76%
Europe (excluding Belgium)
29.1 %
0 11.8 % 1 29.1 % +252.99%
United States & Canada
21.3 %
0 6.4 % 1 21.3 % +373.08%
Belgium
11.8 %
1 26.0 % 0 11.8 % -35.09%
Rest of the World
5.4 %
-- 0 5.4 % -

Managers

Managers TitleAgeSince
Founder 50 08-01-15
Founder 63 08-01-15
Director of Finance/CFO - 23-10-23
Director of Finance/CFO 45 21-01-25
Chief Operating Officer - 20-03-31
Chief Tech/Sci/R&D Officer - 19-10-31

Members of the board

Members of the board TitleAgeSince
Founder 63 08-01-15
Director/Board Member 62 20-10-25
Founder 50 08-01-15
Director of Finance/CFO 45 21-01-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 126,716,822 55,687,468 ( 43.95 %) 0 43.95 %

Shareholders

NameEquities%Valuation
Mercia Fund Management Ltd.
14.85 %
18,071,000 14.85 % 2 M $
13,178,467 10.83 % 2 M $
Hargreaves Lansdown Asset Management Ltd.
8.572 %
10,433,000 8.572 % 1 M $
7,888,844 6.481 % 987 762 $
Catenalucis LLC
6.234 %
7,588,000 6.234 % 950 093 $
Thornapple LLP
5.452 %
6,636,000 5.452 % 830 894 $
4,817,000 3.958 % 603 137 $
Touchstone Innovations Investment Management Ltd.
3.422 %
4,165,000 3.422 % 521 500 $
Unicorn Asset Management Ltd.
1.584 %
1,927,750 1.584 % 241 374 $
Melanie Ross
0.004108 %
5,000 0.004108 % 626 $

Company contact information

Abingdon Health Plc

York Biotech Campus Sand Hutton

YO41 1LZ, York

+44 19 0440 6050

http://www.abingdonhealth.com
address Abingdon Health Plc(ABDXF)